Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com

Educational video content for better cellular starting material strategy
The Leukopak Lady is an educational video series created by Jennifer Chain, PhD, CABP, CAPM, to help cell therapy developers, collection centers, suppliers, and industry partners think more strategically about leukopaks and cellular starting materials.
In cell and gene therapy, starting material quality can shape everything that happens downstream. A leukopak may meet basic specifications and still perform differently in manufacturing due to a multitude of issues. The Leukopak Lady was created to make these issues easier to understand and more visible across the advanced therapies ecosystem.
Through short, focused videos, the series explores practical and scientific topics such as donor qualification, mobilized and non-mobilized collections, T cell and NK cell considerations, cryopreservation effects, master donor banks, pooling strategies, collection center alignment, and why conventional leukopak specifications may not always predict manufacturing success.
For therapy developers, the series offers a practical framework for thinking upstream before downstream problems appear. For collection centers and suppliers, it highlights the opportunity to move beyond transactional collection services and become stronger strategic partners to cell therapy developers.
The Leukopak Lady is designed for professionals working across CGT development, CMC, process development, quality, regulatory, clinical operations, business development, supplier management, and collection operations. Each episode translates technical starting material issues into practical considerations that support better planning, stronger alignment, and more consistent cell therapy programs.
The series is part of Jennifer Chain’s broader work in Scientific Affairs and cellular starting material strategy through Cells Matter.
Learn more:
Visit The Leukopak Lady on YouTube: